Trandolapril in patients with essential hypertension: Effects on vascular and cardiac structural changes

V. Rendina, G. Iaccarino, R. Russo, J. Enea, R. Marchegiano, G. Lembo, B. Trimarco

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Elevated arterial pressure levels increase the hemodynamic load on heart and vessels, thus leading to functional and structural abnormalities. Because cardiac and vascular changes increase the risk of cardiovascular disease, their reversal is an important target of antihypertensive therapy, even though the prognostic value of this regression has not been fully established. In patients with untreated mild-to-moderate essential hypertension and left ventricular hypertrophy, trandolapril, a new angiotensin-converting enzyme inhibitor, reduces blood pressure by decreasing total peripheral resistance and improves both systolic and diastolic ventricular function. The latter effect is not only functional in nature because, after long-term antihypertensive treatment, the improvement in diastolic ventricular function is detectable also after 1-month withdrawal of trandolapril. The concurrent reversal of left ventricular hypertrophy may contribute to the improved left ventricular diastolic function. However, plethysmographic studies suggest that long-term antihypertensive treatment with trandolapril is also able to reverse structural vascular changes in the forearm vascular bed, because after 1-month washout forearm peripheral resistance also is lower than in control conditions. Finally, in hypertensive patients, trandolapril induces significant increases in brachial artery compliance and diameter that persist after 1 month of withdrawal from treatment. The latter observation suggests that trandolapril also is able to reverse the structural changes of the large artery wall. The uniform regression of the hypertension-induced structural changes in the heart and in the large as well as the small arteries induced by trandolapril suggests that this drug exerts a significant protective effect against the risk of cardiovascular disease associated with systemic essential hypertension.

Original languageEnglish
JournalJournal of Cardiovascular Pharmacology
Volume23
Issue numberSUPPL. 1
Publication statusPublished - 1994

Fingerprint

trandolapril
Blood Vessels
Antihypertensive Agents
Ventricular Function
Left Ventricular Hypertrophy
Forearm
Vascular Resistance
Cardiovascular Diseases
Arteries
Brachial Artery
Therapeutics
Left Ventricular Function
Angiotensin-Converting Enzyme Inhibitors
Compliance
Essential Hypertension
Arterial Pressure
Hemodynamics
Observation

Keywords

  • Large artery compliance
  • Left ventricular diastolic function
  • Left ventricular hypertrophy
  • Systemic hemodynamics

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Rendina, V., Iaccarino, G., Russo, R., Enea, J., Marchegiano, R., Lembo, G., & Trimarco, B. (1994). Trandolapril in patients with essential hypertension: Effects on vascular and cardiac structural changes. Journal of Cardiovascular Pharmacology, 23(SUPPL. 1).

Trandolapril in patients with essential hypertension : Effects on vascular and cardiac structural changes. / Rendina, V.; Iaccarino, G.; Russo, R.; Enea, J.; Marchegiano, R.; Lembo, G.; Trimarco, B.

In: Journal of Cardiovascular Pharmacology, Vol. 23, No. SUPPL. 1, 1994.

Research output: Contribution to journalArticle

Rendina, V, Iaccarino, G, Russo, R, Enea, J, Marchegiano, R, Lembo, G & Trimarco, B 1994, 'Trandolapril in patients with essential hypertension: Effects on vascular and cardiac structural changes', Journal of Cardiovascular Pharmacology, vol. 23, no. SUPPL. 1.
Rendina, V. ; Iaccarino, G. ; Russo, R. ; Enea, J. ; Marchegiano, R. ; Lembo, G. ; Trimarco, B. / Trandolapril in patients with essential hypertension : Effects on vascular and cardiac structural changes. In: Journal of Cardiovascular Pharmacology. 1994 ; Vol. 23, No. SUPPL. 1.
@article{63d9c5ca637c4391ab9592033fb69538,
title = "Trandolapril in patients with essential hypertension: Effects on vascular and cardiac structural changes",
abstract = "Elevated arterial pressure levels increase the hemodynamic load on heart and vessels, thus leading to functional and structural abnormalities. Because cardiac and vascular changes increase the risk of cardiovascular disease, their reversal is an important target of antihypertensive therapy, even though the prognostic value of this regression has not been fully established. In patients with untreated mild-to-moderate essential hypertension and left ventricular hypertrophy, trandolapril, a new angiotensin-converting enzyme inhibitor, reduces blood pressure by decreasing total peripheral resistance and improves both systolic and diastolic ventricular function. The latter effect is not only functional in nature because, after long-term antihypertensive treatment, the improvement in diastolic ventricular function is detectable also after 1-month withdrawal of trandolapril. The concurrent reversal of left ventricular hypertrophy may contribute to the improved left ventricular diastolic function. However, plethysmographic studies suggest that long-term antihypertensive treatment with trandolapril is also able to reverse structural vascular changes in the forearm vascular bed, because after 1-month washout forearm peripheral resistance also is lower than in control conditions. Finally, in hypertensive patients, trandolapril induces significant increases in brachial artery compliance and diameter that persist after 1 month of withdrawal from treatment. The latter observation suggests that trandolapril also is able to reverse the structural changes of the large artery wall. The uniform regression of the hypertension-induced structural changes in the heart and in the large as well as the small arteries induced by trandolapril suggests that this drug exerts a significant protective effect against the risk of cardiovascular disease associated with systemic essential hypertension.",
keywords = "Large artery compliance, Left ventricular diastolic function, Left ventricular hypertrophy, Systemic hemodynamics",
author = "V. Rendina and G. Iaccarino and R. Russo and J. Enea and R. Marchegiano and G. Lembo and B. Trimarco",
year = "1994",
language = "English",
volume = "23",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Trandolapril in patients with essential hypertension

T2 - Effects on vascular and cardiac structural changes

AU - Rendina, V.

AU - Iaccarino, G.

AU - Russo, R.

AU - Enea, J.

AU - Marchegiano, R.

AU - Lembo, G.

AU - Trimarco, B.

PY - 1994

Y1 - 1994

N2 - Elevated arterial pressure levels increase the hemodynamic load on heart and vessels, thus leading to functional and structural abnormalities. Because cardiac and vascular changes increase the risk of cardiovascular disease, their reversal is an important target of antihypertensive therapy, even though the prognostic value of this regression has not been fully established. In patients with untreated mild-to-moderate essential hypertension and left ventricular hypertrophy, trandolapril, a new angiotensin-converting enzyme inhibitor, reduces blood pressure by decreasing total peripheral resistance and improves both systolic and diastolic ventricular function. The latter effect is not only functional in nature because, after long-term antihypertensive treatment, the improvement in diastolic ventricular function is detectable also after 1-month withdrawal of trandolapril. The concurrent reversal of left ventricular hypertrophy may contribute to the improved left ventricular diastolic function. However, plethysmographic studies suggest that long-term antihypertensive treatment with trandolapril is also able to reverse structural vascular changes in the forearm vascular bed, because after 1-month washout forearm peripheral resistance also is lower than in control conditions. Finally, in hypertensive patients, trandolapril induces significant increases in brachial artery compliance and diameter that persist after 1 month of withdrawal from treatment. The latter observation suggests that trandolapril also is able to reverse the structural changes of the large artery wall. The uniform regression of the hypertension-induced structural changes in the heart and in the large as well as the small arteries induced by trandolapril suggests that this drug exerts a significant protective effect against the risk of cardiovascular disease associated with systemic essential hypertension.

AB - Elevated arterial pressure levels increase the hemodynamic load on heart and vessels, thus leading to functional and structural abnormalities. Because cardiac and vascular changes increase the risk of cardiovascular disease, their reversal is an important target of antihypertensive therapy, even though the prognostic value of this regression has not been fully established. In patients with untreated mild-to-moderate essential hypertension and left ventricular hypertrophy, trandolapril, a new angiotensin-converting enzyme inhibitor, reduces blood pressure by decreasing total peripheral resistance and improves both systolic and diastolic ventricular function. The latter effect is not only functional in nature because, after long-term antihypertensive treatment, the improvement in diastolic ventricular function is detectable also after 1-month withdrawal of trandolapril. The concurrent reversal of left ventricular hypertrophy may contribute to the improved left ventricular diastolic function. However, plethysmographic studies suggest that long-term antihypertensive treatment with trandolapril is also able to reverse structural vascular changes in the forearm vascular bed, because after 1-month washout forearm peripheral resistance also is lower than in control conditions. Finally, in hypertensive patients, trandolapril induces significant increases in brachial artery compliance and diameter that persist after 1 month of withdrawal from treatment. The latter observation suggests that trandolapril also is able to reverse the structural changes of the large artery wall. The uniform regression of the hypertension-induced structural changes in the heart and in the large as well as the small arteries induced by trandolapril suggests that this drug exerts a significant protective effect against the risk of cardiovascular disease associated with systemic essential hypertension.

KW - Large artery compliance

KW - Left ventricular diastolic function

KW - Left ventricular hypertrophy

KW - Systemic hemodynamics

UR - http://www.scopus.com/inward/record.url?scp=0028326073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028326073&partnerID=8YFLogxK

M3 - Article

C2 - 7519692

AN - SCOPUS:0028326073

VL - 23

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - SUPPL. 1

ER -